These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

462 related items for PubMed ID: 12094862

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Budesonide versus mesalamine for maintaining remission in patients refusing other immunomodulators for steroid-dependent Crohn's disease.
    Mantzaris GJ, Petraki K, Sfakianakis M, Archavlis E, Christidou A, Chadio-Iordanides H, Triadaphyllou G.
    Clin Gastroenterol Hepatol; 2003 Mar; 1(2):122-8. PubMed ID: 15017504
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Comparison between high dose 5-aminosalicylic acid and 6-methylprednisolone in active Crohn's ileocolitis. A multicenter randomized double-blind study. German 5-ASA Study Group.
    Gross V, Andus T, Fischbach W, Weber A, Gierend M, Hartmann F, Schölmerich J.
    Z Gastroenterol; 1995 Oct; 33(10):581-4. PubMed ID: 7502549
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Relationship between clinical features of Crohn's disease and the risk of developing extraintestinal manifestations.
    Barreiro-de Acosta M, Domínguez-Muñoz JE, Núñez-Pardo de Vera MC, Lozano-León A, Lorenzo A, Peña S.
    Eur J Gastroenterol Hepatol; 2007 Jan; 19(1):73-8. PubMed ID: 17206080
    [Abstract] [Full Text] [Related]

  • 27. Perianal Crohn's disease and pregnancy: role of the mode of delivery.
    Ilnyckyji A, Blanchard JF, Rawsthorne P, Bernstein CN.
    Am J Gastroenterol; 1999 Nov; 94(11):3274-8. PubMed ID: 10566729
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Budesonide in glucocorticoid dependent chronic active Crohn's disease; a pilot study.
    Novacek G, Kleinberger M, Vogelsang H, Moser G, Lochs H.
    Z Gastroenterol; 1995 May; 33(5):251-4. PubMed ID: 7610692
    [Abstract] [Full Text] [Related]

  • 34. Review article: treatment of perianal fistulizing Crohn's disease.
    Rutgeerts P.
    Aliment Pharmacol Ther; 2004 Oct; 20 Suppl 4():106-10. PubMed ID: 15352905
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Factors associated with the development of intestinal strictures or obstructions in patients with Crohn's disease.
    Lichtenstein GR, Olson A, Travers S, Diamond RH, Chen DM, Pritchard ML, Feagan BG, Cohen RD, Salzberg BA, Hanauer SB, Sandborn WJ.
    Am J Gastroenterol; 2006 May; 101(5):1030-8. PubMed ID: 16606351
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Azathioprine as a postoperative prophylaxis reduces symptoms in aggressive Crohn's disease.
    Myrelid P, Svärm S, Andersson P, Almer S, Bodemar G, Olaison G.
    Scand J Gastroenterol; 2006 Oct; 41(10):1190-5. PubMed ID: 16990204
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 24.